Several studies have reported that LPIN1 is upregulated in several cancers, including breast cancer and prostate cancer, and its expression levels are positively correlated with the poor prognosis of triple-negative breast cancer and lung adenocarcinoma [15,16]. The gene discussed is LPIN1; the disease is prostate cancer.